Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha.

The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies

1993 • 1,444 citations

A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

1990 • 855 citations

Transforming Growth Factors β1 and α in Chronic Liver Disease

1991 • 655 citations

Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B

1988 • 431 citations

Long-Term Remission of Chronic Hepatitis B after Alpha-Interferon Therapy

1991 • 415 citations

Radioimmunoassay for type III procollagen peptide and its application to human liver disease

1979 • 396 citations

Selective inhibition of human diploid fibroblast collagen synthesis by interferons.

1984 • 336 citations

Book Review Ethical Problems in Dialysis and Transplantation (Developments in Nephrology. Vol. 33.) Edited by Carl M. Kjellstrand and John B. Dossetor. 235 pp., illustrated. Boston, Kluwer Academic, 1992. $108.50. 0-7923-1625-8

1993 • 329 citations

Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor β: Implication for a pathogenetic role in alcoholic liver fibrogenesis

1990 • 295 citations

Ultrastructural identification of extension aminopropeptides of type I and III collagens in human skin.

1981 • 224 citations

Degradation of newly synthesized collagen.

1978 • 217 citations

The N-Terminal Propeptide of Collagen Type III in Serum Reflects Activity and Degree of Fibrosis in Patients with Chronic Liver Disease

1984 • 185 citations

Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro

1989 • 178 citations

A Controlled Trial of Intralesional Recombinant Interferon-? in the Treatment of Keloidal Scarring

1990 • 165 citations

Collagen fibril formation during embryogenesis.

1983 • 157 citations

Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis

1984 • 138 citations

Isolation and characterization of pepsin fragments of laminin from human placental and renal basement membranes

1981 • 136 citations

Flowers and the London specialist hospitals.

1980 • 125 citations

Type IV collagen and laminin‐related antigens in human serum in alcoholic liver disease

1985 • 118 citations

Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease

1983 • 117 citations

Principles of Competitive Binding Assays (Saturation Analyses). I. Equilibrium Techniques

1973 • 114 citations

Recombinant interferon-γ in the treatment of systemic sclerosis

1989 • 104 citations

Markers of fibrogenesis and basement membrane formation in alcoholic liver disease

1990 • 104 citations

The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat

1989 • 95 citations

Blood analysis for liver fibrosis

1985 • 94 citations

Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis

1986 • 91 citations

Serum Procollagen Peptides and Collagen Type Vi for the Assessment of Activity and Degree of Hepatic Fibrosis in Schistosomiasis and Alcoholic Liver Disease

1992 • 85 citations

Long-Term Follow-Up of Serum N-Terminal Propeptide of Collagen Type III Levels in Patients with Chronic Liver Disease

1984 • 79 citations

Serum type III procollagen peptide concentrations in severe chronic active hepatitis: Relationship to cirrhosis and disease activity

1987 • 74 citations

α-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers

1993 • 73 citations

TYPE III PROCOLLAGEN PEPTIDE: A MARKER OF DISEASE ACTIVITY AND PROGNOSIS IN PRIMARY BILIARY CIRRHOSIS

1988 • 73 citations

Radioimmunoassay of laminin in serum and its application to cancer patients.

1986 • 72 citations

Serum type III procollagen peptide and laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers

1989 • 67 citations

Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis

1991 • 64 citations

Radioimmunoassay of laminin in serum and its application to cancer patients.

1986 • 59 citations

Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis

1991 • 57 citations

Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload

1985 • 55 citations

A radioimmunoassay procedure for type III procollagen: Its use in the detection of hepatic fibrosis

1985 • 52 citations

Liver Fibrosis in Alcoholics

1986 • 49 citations

Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases.

1988 • 49 citations

Enzymes of collagen synthesis and type III procollagen aminopropeptide in the evaluation of D-penicillamine and medroxyprogesterone treatments of primary biliary cirrhosis.

1983 • 45 citations

Lymphoblastoid alpha-interferon for chronic hepatitis C: a randomized controlled study.

1993 • 41 citations

Biliary Excretion of Procollagen Type III Peptide in Healthy Humans and in Patients With Alcoholic Cirrhosis of the Liver

1983 • 41 citations

The biological basis for clinical use of interferon

1990 • 39 citations

Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propetide of procollagen type III (PIIIP) in chronic liver disease

1990 • 38 citations

Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis

1986 • 34 citations

Serum basement membrane and type III procollagen-related antigens in primary biliary cirrhosis

1988 • 28 citations

Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis

1990 • 27 citations

Clinical Significance of Serum Type-III Procollagen Arninopropeptide in Hepatitis B Virus-Related Liver Diseases

1989 • 26 citations

Serum type III procollagen and basement membrane proteins as noninvasive markers of hepatic pathology in Indian childhood cirrhosis

1987 • 25 citations

Higher levels of aminoterminal type III procollagen peptide, and laminin in alcoholic in nonalcoholic cirrhosis of equal severity

1992 • 21 citations

Serial determinations of the amino-terminal peptide of type III procollagen in severe chronic active hepatitis.

1987 • 21 citations